Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)
Erstveröffentlichung
2009
Beitrag zu einer Konferenz
Published in
Blood ; 113 (2009), 18. - S. 4137-4143. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood-2008-10-184135Institutions
UKU. Klinik für Innere Medizin IIIConference
48th Annual Meeting of the American-Society-of-Hematology, 2006-12-09 - 2006-12-12, Orlando
Subject headings
[Free subject headings]: DOSE DEXAMETHASONE | PLUS DEXAMETHASONE | BORTEZOMIB | COMBINATION | THALIDOMIDE | CYCLOPHOSPHAMIDE | ABNORMALITIES | CHEMOTHERAPY | SURVIVAL | THERAPY[DDC subject group]: DDC 610 / Medicine & health